• contact us
  • |
  • home
  • |
  • rho canada
  • |
  • rho fund investors
  • |
  • twitter   follow us
search
rho Logo
    • Rho Ventures Investing Approach
    • Rho Values
    • Fast Facts
    • Overview
    • Partners
    • Principals
    • Associates
    • Chief Financial Officer
    • General Counsel
    • Key Successes
    • Investments
    • Case Studies
    • Energy Technology
    • Healthcare
    • IT & Communications
    • New Media
    • Jobs @ Rho Companies
    • Portfolio News
    • Rho Ventures News
    • Archived News
Portfolio > Healthcare > Historical > GynoPharma

GynoPharma

Sector:
Healthcare

Year Funded:
1986

Status:
Acquired by Ortho-McNeil (now J&J)



Summary:

GynoPharma was the first to market the ParaGard copper IUD in the United States. 

 

Key Successes
Investments
Case Studies
Energy Technology
Healthcare
Current
Historical
3DP
Archemix
Dendreon
Dyax
Gloucester Pharmaceuticals
GynoPharma
Genetic Therapy
Health Allies
Human Genome Sciences
LeukoSite
MedImmune
Memory Pharmaceuticals
MPV
NitroMed
Osteotech
Pharmavene
Principia
Senomyx
STC
Tercica
TolerRx
Upstate
Vanda
Verathon
Vicuron
Virus Research
IT & Communications
New Media
Jobs @ Rho Companies
  • Copyright © 2010 Rho Ventures. All rights reserved